BIOCON acquisition, merger or stake sale

as of Thu 12 Feb 15:30

BIOCON LIMITED. filed acquisition, merger or stake sale, from employees of the Biocon Group and other shareholders of BBL, its own share being 2% on Thu 12 Feb 2026.

Its size: the filing states no amount.

Another kind of filing reached the market on the same session, so the move that followed is counted with such pairs and not as this filing's own.

Where it came from

as of Thu 12 Feb 15:30
Sources
Filed
NSE · 2026-02-12 19:28 IST
Document
raw/nse_announcement_docs/2026-02-12/cfba1acf85a4_cfba1acf85a4_BIOCON_12022026192802_Outcome_of_BM12022026.pdf · SHA-256 cfba1acf85a4
Read from
“remaining ~2% of BBL’s paid -up equity share capital on fully diluted basis” · page 1 · characters 1961–2037
Read by
claude-sonnet-5 · prompt 8c43350f344fef0c · 9 of 9 checks passed
Measured against
the company’s market value · as of 12 Feb 2026
Kind
acquisition, merger or stake sale

What such filings have been followed by

as of Thu 12 Feb 15:30

This filing has no record: its size is not measured, it states no amount, or it came on the same session as another kind.